As per the March 2022 publication from the Centers for Disease Control and Prevention, chronic diseases afflict 60% of U.S. adults. The escalating prevalence, encompassing cancer and chronic lung diseases, underscores the vital role of transfection technologies in advancing treatments. Innovations addressing chronic diseases contribute to the growing healthcare demand, and the growth of the transfection market and its pivotal role in shaping future therapeutic interventions.
